Lincoln Pharmaceuticals Limited (NSE:LINCOLN)
550.85
-54.70 (-9.03%)
May 22, 2025, 3:30 PM IST
Lincoln Pharmaceuticals Revenue
In the fiscal year ending March 31, 2025, Lincoln Pharmaceuticals had annual revenue of 6.46B INR with 11.22% growth. Lincoln Pharmaceuticals had revenue of 1.61B in the quarter ending March 31, 2025, with 13.20% growth.
Revenue
6.46B
Revenue Growth
+11.22%
P/S Ratio
2.02
Revenue / Employee
3.54M
Employees
1,687
Market Cap
12.06B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 6.46B | 651.58M | 11.22% |
Mar 31, 2024 | 5.81B | 702.41M | 13.76% |
Mar 31, 2023 | 5.10B | 381.86M | 8.09% |
Mar 31, 2022 | 4.72B | 479.38M | 11.30% |
Mar 31, 2021 | 4.24B | 376.95M | 9.75% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 516.03B |
Divi's Laboratories | 90.78B |
Cipla | 271.45B |
Mankind Pharma | 116.41B |
Apollo Hospitals Enterprise | 211.46B |
Zydus Lifesciences | 232.42B |
Aurobindo Pharma | 309.22B |
Alkem Laboratories | 127.57B |